Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Accepting the Bumps in the Road Arts, Education, Song, and Advocacy Programs Awarded 2019 Impact Grants by CFF Use Me for Something Good Mylan Given Rights to Market TOBI Solution and TOBI Podhaler in UK Accepting the Bumps in the Road Jul 26, 2019 09:00 am | Elizabeth Rogers Life with cystic fibrosis (CF) has made me all too aware of the ticking clock. Having a natural tendency to be impatient, I’m a person who wants things done and over with now. Results have to be instant or they’re unsatisfactory. What I want and what my CF demands, however, are two completely different beasts. […] The post Accepting the Bumps in the Road appeared first on Cystic Fibrosis News Today. Read More Arts, Education, Song, and Advocacy Programs Awarded 2019 Impact Grants by CFF Jul 26, 2019 07:00 am | Alice Melão Five programs helping to empower the cystic fibrosis (CF) community were selected to receive up to $10,000 each under the fourth annual Impact Grants awarded by the Cystic Fibrosis Foundation (CFF). Launched in 2016, the Impact Grants program is designed to support new ideas and projects that aim to improve the lives of those with […] The post Arts, Education, Song, and Advocacy Programs Awarded 2019 Impact Grants by CFFappeared first on Cystic Fibrosis News Today. Read More Use Me for Something Good Jul 25, 2019 09:00 am | Elly Aylwin-Foster I’m not sure what I’m here for, but I hope it’s something good. From the ages of 8 to 12, I thought I was designed for warfare. My father served in the military, and don’t we all aspire to do as our parents did? I used to play on deserted assault and training courses, geeing […] The post Use Me for Something Good appeared first on Cystic Fibrosis News Today. Read More Mylan Given Rights to Market TOBI Solution and TOBI Podhaler in UK Jul 25, 2019 07:00 am | Joana Carvalho, MSc The European Commission (EC) and the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) granted Mylan the right to market TOBI Podhaler (tobramycin inhalation powder) and TOBI Solution (tobramycin nebulizer solution) in the United Kingdom, the company announced. The decision came after the Committee on Human Medicinal Products (CHMP) issued a positive recommendation for the transfer of […] The post Mylan Given Rights to Market TOBI Solution and TOBI Podhaler in UK appeared first on Cystic Fibrosis News Today. Read More   Recent News AR-501 Named Orphan Drug in EU as Possible Treatment for Chronic Lung Infections in CF Chronic Bullying Is the Worst Sickness of All Vertex Asks FDA to Approve 1st Triple Combo for CF – Elexacaftor, Tezacaftor and Kalydeco ‘Everything’ Will Never Be Perfect, and That’s OK Kalydeco’s Safety and Benefits Studied in CF Patients with Severe Lung Disease